Xiamen Amoytop Biotech Co., Ltd.

¥45.09As of Sun 8 Nov 2026, 12:00 UTC
SSE:688278Healthcare
Country China
PE (Fwd) •••
TSR 7Y CAGR 1.57%
Div yield 1.38%
ROE 26.98%
Biotechnology
Beta (5Y) (0.03)
PE TTM 21.98
TSR TTM (37.55%)
Mkt cap ¥17.92B
ROIC 29.12%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥48
6.99%
(80.90%)
Hold 9|4|2|4|10
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.49
0.49
0.50
0.54
21.76%
19.95%
14.49%
15.56%
Revenue¥B
1.466
1.530
1.554
1.608
7.44%
10.21%
9.67%
15.05%
Peers (US$2.686B)
Cap (US$)
PE
2.722B
—
2.700B
36.65x
2.683B
—
Capital
TTM
5Y
10Y
Leveragex
0.884
(0.113)
(0.113)
EBIT/Intx
0.134
0.695
0.595
Own earn%
13.37
112.52
111.19
Sh yield%
54.52
41.20
41.16
Owners
Insiders/Inst%
1.02
41.24
Short interest%
3.52
SBC / revenue%
2.16
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
0–8
$1 testx
0.1
Incr. ROIC%
11